The following Dispute Resolution guidance note provides comprehensive and up to date legal information covering:
Private & confidential
[Insert name and address of client]
Dear [Insert name of client]
[Insert case heading and claim number if appropriate]
I refer to my letter of today’s date in which I advise you about the injunctive relief I recommend you seek from [insert name of other party]. The purpose of this letter is to address the need for a cross-undertaking in damages together with the need for the supporting witness statement to contain a statement of truth.
Cross-undertaking in damages
By countersigning this letter, you are [on behalf of [insert client name]] confirming:
your understanding that the court will ask [you OR [insert client name]], as applicant, to give a cross-undertaking in damages in the event that it turns out that the injunction should not have been granted, for example, if relevant information was not provided to the court during the application
that [you OR [insert client name]] undertake to compensate [insert name of other party] for any losses they suffer as a result of the injunction if [you OR [insert client name]] fail to establish a case against [insert name of other party] at trial
your understanding that if
**Trials are provided to all LexisPSL and LexisLibrary content, excluding Practice Compliance, Practice Management and Risk and Compliance, subscription packages are tailored to your specific needs. To discuss trialling these LexisPSL services please email customer service via our online form. Free trials are only available to individuals based in the UK. We may terminate this trial at any time or decide not to give a trial, for any reason. Trial includes one question to LexisAsk during the length of the trial.
To view the latest version of this document and thousands of others like it, sign-in to LexisPSL or register for a free trial.
Existing user? Sign-in
Take a free trial
0330 161 1234
To view our latest legal guidance content,sign-in to Lexis®PSL or register for a free trial.